Prevention and diagnostics of haemolytic disease of the fetus and newborn
Abstract
Haemolytic disease of the newborn (HDN), also known as haemolytic disease of the fetus and newborn (HDFN), develops in the fetus when erythrocyte alloantibodies produced by the mother pass through the placenta. Severe form of HDFN is mainly caused by anti-D antibodies, but it can also be caused by many other types of antibodies, most often by anti-Kell (anti-K), anti-c, anti-E in anti-C. In order to prevent sensitisation to erythrocyte antigens, every pregnant woman is tested for blood group AB0, D, K and for irregular antibodies (IAT–indirect antiglobulin test). For D-negative women IAT is repeated in the 28th week of pregnancy, followed by an injection of anti-D immnunoglobulin (Ig anti-D) when indicated. At the Blood Transfusion Centre of Slovenia, we have recently started to determine the fetal D status from a maternal blood sample in order to avoid the unnecessary application of Ig anti-D to women bearing Dnegative fetuses.Downloads
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
